PCI complications: Hemodynamic Support for Complex PCI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 9: | Line 9: | ||
| bgcolor="LightGreen"|Using an appropriate [[hemodynamic]] support device in the elective settings and among selected [[patients]] is reasonable to [[prevention|prevent]] [[hemodynamic]] compromise during [[PCI]]. | | bgcolor="LightGreen"|Using an appropriate [[hemodynamic]] support device in the elective settings and among selected [[patients]] is reasonable to [[prevention|prevent]] [[hemodynamic]] compromise during [[PCI]]. | ||
|} | |} | ||
==References== | |||
{{reflist|2}} |
Revision as of 09:30, 7 July 2022
Hemodynamic Support for Complex PC
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Anahita Deylamsalehi, M.D.[2]
Overview
2021 ACA Revascularization Guideline
Class 2b Recommendation, Level of Evidence: B-R [1] |
Using an appropriate hemodynamic support device in the elective settings and among selected patients is reasonable to prevent hemodynamic compromise during PCI. |
References
- ↑ Writing Committee Members. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM; et al. (2022). "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". J Am Coll Cardiol. 79 (2): e21–e129. doi:10.1016/j.jacc.2021.09.006. PMID 34895950 Check
|pmid=
value (help).